title: AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016--EXECUTIVE SUMMARY.
abstract: AACE = American Association of Clinical Endocrinologists AFF = atypical femur fracture ASBMR = American Society for Bone and Mineral Research BEL = best evidence level BMD = bone mineral density BTM = bone turnover marker CBC = complete blood count CI = confidence interval DXA = dual-energy X-ray absorptiometry EL = evidence level FDA = U.S. Food and Drug Administration FLEX = Fracture Intervention Trial (FIT) Long-term Extension FRAX(®) = Fracture Risk Assessment Tool GFR = glomerular filtration rate GI = gastrointestinal HORIZON = Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly IOF = International Osteoporosis Foundation ISCD = International Society for Clinical Densitometry IU = international units IV = intravenous LSC = least significant change NBHA = National Bone Health Alliance NOF = National Osteoporosis Foundation 25(OH)D = 25-hydroxy vitamin D ONJ = osteonecrosis of the jaw PINP = serum carboxy-terminal propeptide of type I collagen PTH = parathyroid hormone R = recommendation RANK = receptor activator of nuclear factor kappa-B RANKL = receptor activator of nuclear factor kappa-B ligand RCT = randomized controlled trial RR = relative risk S-CTX = serum C-terminal telopeptide SQ = subcutaneous VFA = vertebral fracture assessment WHO = World Health Organization.
authors.forename: Pauline M
authors.initials: PM
authors.lastname: Camacho
authors.forename: Steven M
authors.initials: SM
authors.lastname: Petak
authors.forename: Neil
authors.initials: N
authors.lastname: Binkley
authors.forename: Bart L
authors.initials: BL
authors.lastname: Clarke
authors.forename: Steven T
authors.initials: ST
authors.lastname: Harris
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Hurley
authors.forename: Michael
authors.initials: M
authors.lastname: Kleerekoper
authors.forename: E Michael
authors.initials: EM
authors.lastname: Lewiecki
authors.forename: Paul D
authors.initials: PD
authors.lastname: Miller
authors.forename: Harmeet S
authors.initials: HS
authors.lastname: Narula
authors.forename: Rachel
authors.initials: R
authors.lastname: Pessah-Pollack
authors.forename: Vin
authors.initials: V
authors.lastname: Tangpricha
authors.forename: Sunil J
authors.initials: SJ
authors.lastname: Wimalawansa
authors.forename: Nelson B
authors.initials: NB
authors.lastname: Watts
mesh_terms: D015415:Biomarkers / Q000097:blood; D015519:Bone Density; D024042:Collagen Type I / Q000097:blood; D004704:Endocrinology / Q000458:organization & administration / Q000592:standards; D055317:Evidence-Based Practice; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis* / Q000628:therapy*; D058866:Osteoporotic Fractures / Q000175:diagnosis / Q000628:therapy; D010281:Parathyroid Hormone / Q000097:blood; D012955:Societies, Medical / Q000458:organization & administration / Q000592:standards; D014481:United States; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood
chemical_list: D015415:Biomarkers; D024042:Collagen Type I; D010281:Parathyroid Hormone; D014807:Vitamin D; C104450:25-hydroxyvitamin D